THE ROLE OF AT-HOME CONSUMER DIAGNOSTICS INCREASES Saliva-based home pregnancy test arrives at Australian pharmacies
With
Dr Anita Sharma, GP
Platinum Medical Centre,
Brisbane
Michael Cima, CEO & Director
CC Supplies,
Byron Bay
SEGMENT
Filmed in Brisbane | March 2026
Since the COVID-19 pandemic, consumer diagnostics have rapidly advanced, with more people becoming aware of and comfortable using at-home testing. These tests provide greater convenience, control, and empowerment, allowing individuals to monitor their health without immediately consulting a healthcare professional. Recently, this shift has been particularly impactful in areas such as pregnancy testing, where saliva-based diagnostics now enable earlier and more accessible detection.
According to Dr Anita Sharma, a Brisbane based GP at Platinum Medical Centre, traditional medical testing still plays an important role. Situations such as unclear symptoms, early-stage conditions with low detectable markers, or practical limitations—like insufficient saliva samples—may require confirmation through standard clinical methods. Additionally, many patients seek reassurance from healthcare professionals even after receiving positive at-home results, particularly when further care planning is needed.
As a result, the role of healthcare practitioners is evolving, according to Dr Sharma. Rather than acting solely as gatekeepers to testing, they are increasingly becoming interpreters and validators of patient-led diagnostics. According to Dr Sharma, GPs now focus more on guiding care, confirming results, and supporting patient decisions. To do this effectively, Dr Sharma states GPs must stay informed through continuous education, engagement with peers, and awareness of emerging diagnostic technologies and trends in healthcare.
Australian Health Journal also spoke with Michael Cima, CEO and Director of CC Supplies about the accessibility of consumer diagnostics and where women are able to choose how to test, have improved access and opt for privacy.
Source: Adapted from transcript
-
Op-Ed: CGT and proposed RDTI changes creating uncertainty in life sciences
Proposed Budget changes to the Research and Development Tax Incentive (RDTI) will disproportionally impact Australia’s biotech, medtech and health tech sector forcing more home-grown companies to consider moving overseas.
-
Awareness, diagnosis and treatment of Congenital Hypothyroidism
Australian Health Journal spoke to Associate Professor MIchelle Jack about congenital hypothyroidism and newborn screening and her concerns in the varying thresholds for across different states in Australia. Despite the existence of newborn screening programs since the 1970s, there is still controversy surrounding the appropriate screening levels. Congenital hypothyroidism, affecting about one in 3500 infants, can lead to severe intellectual and physical impairment if not diagnosed early. The condition is mainly caused by the thyroid gland’s failure to develop properly, resulting in insufficient thyroid hormone production.
-
Dental and oral health care priorities for the elderly
In 2023, there are a number of changes occurring in dental services including the start of a new Senate inquiry and new registered nurses in residential aged care. Yet in the meantime there are gaps and delays in dental and oral health interventions for elderly Australians, unless training is more widely deployed.
Australian Health Journal spoke to Leonie Short, a dental therapist working for Seniors Dental Care Australia on what she considers are dental and oral health priorities for the elderly, based on her work in the aged, home and disability sectors.
